Information:
Fel:
ID
15646
Beskrivning
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Relapse Evaluation Visit No. 4
Länk
https://clinicaltrials.gov/ct2/show/NCT02419378
Nyckelord
Versioner (1)
- 2016-06-06 2016-06-06 -
Uppladdad den
6 juni 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Relapse Evaluation Visit No. 4: Relapse Confirmation Multiple Sclerosis ALAIN01 NCT02419378
Relapse Evaluation Visit No. 4: Relapse Confirmation Relapse Multiple Sclerosis ALAIN01 NCT02419378
Similar models
Relapse Evaluation Visit No. 4: Relapse Confirmation Relapse Multiple Sclerosis ALAIN01 NCT02419378
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Relapse confirmed
Item
Relapse confirmed yes/no
boolean
C0277556 (UMLS CUI [1,1])
C0750484 (UMLS CUI [1,2])
C0750484 (UMLS CUI [1,2])
Recurrence date
Item
Date of Relapse
date
C0807712 (UMLS CUI [1])
Corticosteroid therapy
Item
Relapse: Corticosteroid therapy yes/no
boolean
C0149783 (UMLS CUI [1])
Relapse: Date of Signature
Item
Relapse: Date of Signature
date
C1519316 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])